논문 목록
19건 · 최신순-
Efficacy and Safety of RelabotulinumtoxinA Liquid Botulinum Toxin in the Treatment of Lateral Canthal Lines: Results From the Phase 3 READY-2 Study.
[BACKGROUND] RelabotulinumtoxinA (RelaBoNT-A) is a complex-free, ready-to-use, liquid botulinum toxin A. [OBJECTIVE] Efficacy/safety of RelaBoNT-A treatment for lateral canthal lines (LCL). [METHODS] Randomized adults received RelaBoNT-A …
-
The History of Dermatologic Surgical Body Sculpting in the New Millennium.
[BACKGROUND] In the year 2000, Dermatologic Surgery featured a series of Millennial Articles which reviewed the many contributions of this journal to our field. "The History of Liposuction" appropriately focused on the evolution of this gro…
-
Efficacy and Safety of LetibotulinumtoxinA in the Treatment of Moderate and Severe Glabellar Lines in Females 35 to 50 Years of Age: Post Hoc Analyses of the Phase 3 Clinical Study Data.
[BACKGROUND] Botulinum toxin type A (BoNT-A) injections continue to be widely used as a common treatment for both males and females. According to a recent survey conducted by the International Society of Plastic Aesthetic Surgeons, the majo…
-
PrabotulinumtoxinA for the treatment of glabellar lines in adults, 65 years of age and older: The fourth in a series of post hoc analyses of the phase III clinical study data.
[BACKGROUND] Despite the absence of Phase III clinical trial data to support their use, 3.4% of all neurotoxin treatments performed internationally for esthetic purposes in 2020 were performed in patients 65 years of age and older. [OBJECT…
-
Infraorbital Hollow Rejuvenation: Considerations, Complications, and the Contributions of Midface Volumization.
Infraorbital hollows are one of the most common target areas for facial aesthetic treatment; however, they are often perceived to be challenging to treat due to the complex anatomy of the periorbital area, concurrent deformities, and risk o…
-
Subject satisfaction and psychological well-being with escalating abobotulinumtoxinA injection dose for the treatment of moderate to severe glabellar lines.
[BACKGROUND] Previous studies indicate that the efficacy and durability of a single AbobotulinumtoxinA (ABO) treatment for moderate to severe glabellar lines may be enhanced with increasing dose, while safety outcomes remain consistent with…
-
A Randomized, Controlled, Evaluator-Blinded, Multi-Center Study of Hyaluronic Acid Filler Effectiveness and Safety in Lip Fullness Augmentation.
[BACKGROUND] HARK was recently approved in the US for lip augmentation and correction of upper perioral rhytids. [OBJECTIVE] To demonstrate noninferiority of HARK versus a control (HAJV) in lip fullness augmentation at Week 8 after last in…
-
Safety and Effectiveness of Hyaluronic Acid Filler, VYC-20L, via Cannula for Cheek Augmentation: A Randomized, Single-Blind, Controlled Study.
[BACKGROUND] Using cannulas to deliver facial fillers may reduce adverse events (AEs) compared with needle injection. [OBJECTIVE] To evaluate the safety and effectiveness of VYC-20L (20 mg/mL hyaluronic acid gel with lidocaine) via cannula…
-
Botulinum Toxin Type A for Glabellar Frown Lines: What Impact of Higher Doses on Outcomes?
Botulinum toxin serotype-A (BoNT-A) preparations are widely used to improve the appearance of wrinkles. While effective and well tolerated, patients require retreatment over time to re-establish the effects. There is growing interest from p…
-
The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.
[BACKGROUND] PrabotulinumtoxinA is a 900-kDa botulinum toxin type A produced by Clostridium botulinum. [OBJECTIVES] The authors sought to investigate the safety of prabotulinumtoxinA for treatment of glabellar lines. [METHODS] This was a …
- Early-Onset Sweet-like Dermatitis After Facial Hyaluronic Acid Filler Injection.
-
CME: Re-examining the Optimal Use of Neuromodulators and the Changing Landscape: A Consensus Panel Update.
Since initial US Food and Drug Administration approval of botulinum toxin type A (BoNT-A) for aesthetic use in 2002, clinical evidence and experience with BoNT-A and understanding of facial anatomy have greatly increased, leading to rapid a…
- Commentary on Weight Loss: How Does It Fit in With Liposuction?
-
Re-examining the Optimal Use of Neuromodulators and the Changing Landscape: A Consensus Panel Update.
Since initial US Food and Drug Administration approval of botulinum toxin type A (BoNT-A) for aesthetic use in 2002, clinical evidence and experience with BoNT-A and understanding of facial anatomy have greatly increased, leading to rapid a…
-
Efficacy and safety of a new resilient hyaluronic acid dermal filler, in the correction of moderate-to-severe nasolabial folds: A 64-week, prospective, multicenter, controlled, randomized, double-blind and within-subject study.
[BACKGROUND] Injectables that behave similarly to native tissue and preserve facial expressiveness represent a new frontier in aesthetic medicine. A range of fillers made of high molecular weight hyaluronic acid (HA) chains with low crossli…
-
Neck Rejuvenation Using a Combination Approach: Our Experience and a Review of the Literature.
[BACKGROUND] Aging of the neck is characterized by changes that include skin dyspigmentation, laxity, rhytides, loss of the mandibular contour, widening of the cervicomental angle, accumulation of submental fat, volume loss and prominence o…
-
A Multicenter, Single-Blind Randomized, Controlled Study of a Volumizing Hyaluronic Acid Filler for Midface Volume Deficit: Patient-Reported Outcomes at 2 Years.
[BACKGROUND] Juvéderm Voluma XC is a volumizing hyaluronic acid filler used for correction of age-related midface volume deficit (MVD). [OBJECTIVES] The effectiveness of Juvéderm Voluma XC was examined from the patient perspective. [METHO…
- Commentary on a Pilot Study on the Treatment of Posterior Cheek Enlargement in HIV+ Patients With Botulinum Toxin A.
- In defense of cosmetic surgery for aging.